Fig. 2From: Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in SenegalVirologic and drug resistance testing performed in RESIST-2 Trial. *One additional participant had a genotypic test performed with a viral load of 222, which did not meet criteria for virologic failureBack to article page